Meridian Bioscience, Inc. (VIVO)
Chart Events
Performance Outlook
| Previous Close | 20.72 |
| Open | 20.84 |
| Bid | 20.89 x 1200 |
| Ask | 20.93 x 900 |
| Day's Range | 20.71 - 21.15 |
| 52 Week Range | 12.98 - 30.65 |
| Volume | 86,524 |
| Avg. Volume | 622,337 |
| Market Cap | 905.597M |
| Beta (5Y Monthly) | 0.48 |
| PE Ratio (TTM) | 10.45 |
| EPS (TTM) | 2.00 |
| Earnings Date | Aug 05, 2021 - Aug 09, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Feb 01, 2019 |
| 1y Target Est | 29.67 |
Fair Value
Related Research
- GlobeNewswire
Meridian’s New Master Mix for LAMP Assays Offers a Practical Solution for POC Molecular Detection of RNA viruses
CINCINNATI, June 16, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of the Lyo-Ready™ RT-LAMP Mix, specifically designed for accelerating the development of ambient temperature stable reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) assays. The Lyo-Ready™ RT-LAMP Mix is formulated for rapid, robust, and sensitive detection of RNA viruses. RT-LAMP technol
- Zacks
Meridian Bioscience (VIVO) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Meridian Bioscience (VIVO) closed at $20.88, marking a +1.11% move from the previous day.
- GlobeNewswire
Meridian Bioscience to Participate in the 41st Annual William Blair Growth Stock Conference and Jefferies Virtual Healthcare Conference
CINCINNATI, May 27, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today participation in two upcoming investor conferences. Jack Kenny, Chief Executive Officer, will participate in a live, virtual fireside chat at the 41st Annual William Blair Growth Stock Conference on Wednesday, June 2, 2021 at 4:20 PM ET. Jack Kenny will also pre-record a presentation for the Jefferies Virtual Healthcare Conference which will be webcast on Friday, June 4, 2021 at 2:00 PM ET. Jack Kenny will be taking 1x1 meetings at the William Blair conference while Bryan Baldasare, Executive Vice President and Chief Financial Officer, and Charlie Wood, Vice President – Investor Relations, are taking 1x1 meetings at the Jefferies conference. To access these presentations, go the Events & Presentations section of the Company’s Investor Relations website at https://investor.meridianbioscience.com/. Participants should register several minutes in advance of the William Blair event’s start time by following the link provided for the event. A recording of this event will be available for 30 days. The pre-recorded presentation for the Jefferies event will be made available for 90 days starting June 4. About Meridian Bioscience, Inc.Meridian is a fully integrated life science company that develops, manufactures, markets, and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy, and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world. Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com. Contact:Charlie WoodVice President – Investor RelationsMeridian Bioscience, Inc.Phone: +1 513.271.3700Email: mbi@meridianbioscience.com
